How Trump's Drug Tariffs Could Hit Millions of Americans' Medicine Bills
Summary
President Donald Trump announced plans to impose large tariffs on imported generic drugs starting in 2028. Experts warn this could cause shortages of these medications and raise medicine costs for many Americans who rely on them.Key Facts
- Starting in 2028, imported generic drugs will face a 100% tariff, increasing to 200% in 2029.
- The tariffs aim to encourage drug companies to build factories in the United States.
- Generic drugs make up about 90% of U.S. prescriptions, with many made overseas.
- About 50% of generic drugs come from India; 17% of drug ingredients come from China.
- Experts warn two years is not enough time to replace imports with U.S. production, risking drug shortages.
- Prices for branded drugs (not affected by tariffs) have risen 81% since entering the market.
- Increased tariffs on generics could lead to higher costs for patients and insurance companies.
- Natural disasters have previously disrupted U.S. drug supply chains, highlighting existing vulnerabilities.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
